Stentys

Devices for the treatment of acute myocardial infarction and other coronary diseases

placeParis, Ile De France, France calendar_todayFounded 2006 groups26 employees language stentys.com

Innovation

4 patent families (4 granted) — focus: Human necessities; filing pace dormant. Cited 228 times.

YearFilings
20122
20131
20153

Investor mix

6 investors on record; lead investors include Crédit Agricole Private Equity, Scottish Equity Partners, Sofinnova Partners.

Investor typeCountShare
Venture capital233%
Private equity233%
Bank & private debt233%
Coming soon